467 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
« prev | Page next »
DNAJC14 DnaJ (Hsp40) homolog, subfamily C, member 14 Predicted intracellular proteins Expressed in all
DOLPP1 Dolichyldiphosphatase 1 Enzymes Vesicles Expressed in all
DPY19L1 Dpy-19-like 1 (C. elegans) Predicted intracellular proteins Vesicles Expressed in all
DRD2 Dopamine receptor D2 FDA approved drug targets Tissue enriched
EBPL Emopamil binding protein-like Predicted membrane proteins Endoplasmic reticulum Expressed in all
EI24 Etoposide induced 2.4 Cancer-related genes Endoplasmic reticulum Tissue enriched
ELOVL5 ELOVL fatty acid elongase 5 Disease related genes Endoplasmic reticulum Expressed in all
ELOVL7 ELOVL fatty acid elongase 7 Enzymes Mixed
EMP1 Epithelial membrane protein 1 Predicted intracellular proteins Nucleoplasm Expressed in all
FA2H Fatty acid 2-hydroxylase Disease related genes Nuclear membrane Tissue enhanced
FADS1 Fatty acid desaturase 1 FDA approved drug targets Expressed in all
FADS3 Fatty acid desaturase 3 Predicted intracellular proteins Expressed in all
FAIM2 Fas apoptotic inhibitory molecule 2 Predicted membrane proteins Intermediate filaments Tissue enriched
FAM134A Family with sequence similarity 134, member A Predicted intracellular proteins Cytosol Expressed in all
FAM189A1 Family with sequence similarity 189, member A1 Predicted membrane proteins Nucleus Tissue enhanced
FAM189B Family with sequence similarity 189, member B Predicted membrane proteins Nucleoplasm Mixed
FAM26E Family with sequence similarity 26, member E Predicted membrane proteins Golgi apparatus Mixed
FPR1 Formyl peptide receptor 1 G-protein coupled receptors Nucleus Tissue enhanced
GABRA1 Gamma-aminobutyric acid (GABA) A receptor, alpha 1 Disease related genes Tissue enriched
GABRA3 Gamma-aminobutyric acid (GABA) A receptor, alpha 3 FDA approved drug targets Tissue enriched
GABRA5 Gamma-aminobutyric acid (GABA) A receptor, alpha 5 FDA approved drug targets Cell Junctions Tissue enriched
GABRA6 Gamma-aminobutyric acid (GABA) A receptor, alpha 6 FDA approved drug targets Tissue enhanced
GABRB1 Gamma-aminobutyric acid (GABA) A receptor, beta 1 FDA approved drug targets Tissue enriched
GABRB2 Gamma-aminobutyric acid (GABA) A receptor, beta 2 FDA approved drug targets Tissue enriched
GABRD Gamma-aminobutyric acid (GABA) A receptor, delta Disease related genes Golgi apparatus Tissue enriched
GABRE Gamma-aminobutyric acid (GABA) A receptor, epsilon FDA approved drug targets Tissue enhanced
GABRG1 Gamma-aminobutyric acid (GABA) A receptor, gamma 1 FDA approved drug targets Tissue enriched
GABRG3 Gamma-aminobutyric acid (GABA) A receptor, gamma 3 FDA approved drug targets Tissue enhanced
GABRP Gamma-aminobutyric acid (GABA) A receptor, pi FDA approved drug targets Expressed in all
GABRQ Gamma-aminobutyric acid (GABA) A receptor, theta FDA approved drug targets Tissue enhanced
GJA1 Gap junction protein, alpha 1, 43kDa Cancer-related genes Tissue enhanced
GJA10 Gap junction protein, alpha 10, 62kDa Predicted membrane proteins Not detected
GJA4 Gap junction protein, alpha 4, 37kDa Predicted membrane proteins Tissue enhanced
GJA5 Gap junction protein, alpha 5, 40kDa Disease related genes Tissue enhanced
GJB1 Gap junction protein, beta 1, 32kDa Disease related genes Tissue enhanced
GJB2 Gap junction protein, beta 2, 26kDa Disease related genes Mitochondria Tissue enriched
GJB3 Gap junction protein, beta 3, 31kDa Disease related genes Vesicles Tissue enhanced
GJB4 Gap junction protein, beta 4, 30.3kDa Disease related genes Cell Junctions Tissue enriched
GJB5 Gap junction protein, beta 5, 31.1kDa Cancer-related genes Group enriched
GJB6 Gap junction protein, beta 6, 30kDa Disease related genes Cell Junctions Group enriched
GJC1 Gap junction protein, gamma 1, 45kDa Predicted intracellular proteins Nucleoli Tissue enhanced
GJD2 Gap junction protein, delta 2, 36kDa Predicted membrane proteins Group enriched
GJD4 Gap junction protein, delta 4, 40.1kDa Predicted membrane proteins Mixed
GJE1 Gap junction protein, epsilon 1, 23kDa Predicted membrane proteins Not detected
GLRA1 Glycine receptor, alpha 1 Disease related genes Not detected
GLRA2 Glycine receptor, alpha 2 FDA approved drug targets Group enriched
GLRB Glycine receptor, beta Disease related genes Tissue enhanced
GPAT4 Glycerol-3-phosphate acyltransferase 4 Enzymes Expressed in all
GPM6A Glycoprotein M6A Predicted intracellular proteins Tissue enriched
GPM6B Glycoprotein M6B Predicted membrane proteins Tissue enriched
« prev | Page next »
